Results 171 to 180 of about 715,082 (295)

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

A Case Report on a Paratesticular Tumor Mass: A Myxoid Spindle Cell Neoplasm With Angiomyxoma Features. [PDF]

Cureus
Abraham SM, Gavric L, Devora D, Soukieh MR, Fountain MW.   +4 more
europepmc   +1 more source

Bronchogenic Neoplasms [PDF]

, 1939
Henry D. Rentschler, J. Chalmers Bryson
openalex   +1 more source

Myeloproliferative neoplasms

HemaSphere, 2019
openaire   +3 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

A recent update on the morphological classification of intraductal papillary neoplasm of the bile duct: Correlation with postoperative prognosis and pathological features. [PDF]

PLoS One
Noguchi D, Kuriyama N, Kozuka Y, Komatubara H, Sakamoto T, Ito T, Hayasaki A, Iizawa Y, Fujii T, Tanemura A, Murata Y, Kishiwada M, Mizuno S.   +12 more
europepmc   +1 more source

Neoplasms in Cats [PDF]

Proceedings of the Royal Society of Medicine, 1952
openaire   +3 more sources

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

Leukemia, 2014
M. Sapienza, F. Fuligni, C. Agostinelli, C. Tripodo, S. Righi, M. Laginestra, A. Pileri, M. Mancini, M. Rossi, Francesca Ricci, A. Gazzola, F. Melle, C. Mannu, Francesca Ulbar, M. Arpinati, M. Paulli, T. Maeda, D. Gibellini, L. Pagano, N. Pimpinelli, M. Santucci, L. Cerroni, C. Croce, F. Facchetti, P. Piccaluga, S. Pileri   +25 more
semanticscholar   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Spontaneous Rupture of Solid Pseudopapillary Neoplasm of the Pancreas: A Case Report and Literature Review. [PDF]

Surg Case Rep
Nakaguchi Y, Kishi S, Shirakami N, Ito T, Ohnishi T.   +4 more
europepmc   +1 more source